Literature DB >> 8612580

Interferon-alpha-induced phosphorylation and activation of cytosolic phospholipase A2 is required for the formation of interferon-stimulated gene factor three.

V Flati1, S J Haque, B R Williams.   

Abstract

Treatment of cells with interferon (IFN)-alpha caused phosphorylation and activation of cytosolic phospholipase A2 (cPLA2). The protein tyrosine kinase Jak1 was found to be necessary for the activation of cPLA2. Jak1 could be co-immunoprecipitated with cPLA2 from cell extracts, indicating that a close physical interaction occurs between these two proteins. The induction of IFN-stimulated gene factor three (ISGF3) by IFN-alpha, is blocked by cPLA2 inhibitors in cell cultures and in cell-free reconstituted systems. However, these inhibitors do not block IFN-alpha or gamma-induced binding of STAT1 to the inverted repeat (IR) element of the IFN regulatory factor 1 (IRF-1) gene. Thus, cPLA2 activations occurs as an early event in the IFN-alpha response and is selectively involved in ISGF3-dependent gene activation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8612580      PMCID: PMC450066     

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  59 in total

Review 1.  Leukotrienes and lipoxins: structures, biosynthesis, and biological effects.

Authors:  B Samuelsson; S E Dahlén; J A Lindgren; C A Rouzer; C N Serhan
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

2.  Rapid activation by interferon alpha of a latent DNA-binding protein present in the cytoplasm of untreated cells.

Authors:  T C Dale; A M Imam; I M Kerr; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

3.  Interferon-induced expression of different genes is mediated by distinct regulatory pathways.

Authors:  B Shan; J A Lewis
Journal:  Virology       Date:  1989-05       Impact factor: 3.616

4.  Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional control.

Authors:  D E Levy; D S Kessler; R Pine; N Reich; J E Darnell
Journal:  Genes Dev       Date:  1988-04       Impact factor: 11.361

5.  Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid.

Authors:  J J Seilhamer; W Pruzanski; P Vadas; S Plant; J A Miller; J Kloss; L K Johnson
Journal:  J Biol Chem       Date:  1989-04-05       Impact factor: 5.157

6.  Structure and properties of a human non-pancreatic phospholipase A2.

Authors:  R M Kramer; C Hession; B Johansen; G Hayes; P McGray; E P Chow; R Tizard; R B Pepinsky
Journal:  J Biol Chem       Date:  1989-04-05       Impact factor: 5.157

7.  Interferon-responsive regulatory elements in the promoter of the human 2',5'-oligo(A) synthetase gene.

Authors:  P Benech; M Vigneron; D Peretz; M Revel; J Chebath
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

8.  Interferon-induced binding of nuclear factors to promoter elements of the 2-5A synthetase gene.

Authors:  M N Rutherford; G E Hannigan; B R Williams
Journal:  EMBO J       Date:  1988-03       Impact factor: 11.598

9.  Interferon response element of the human gene 6-16.

Authors:  A C Porter; Y Chernajovsky; T C Dale; C S Gilbert; G R Stark; I M Kerr
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

10.  A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6.

Authors:  D Guschin; N Rogers; J Briscoe; B Witthuhn; D Watling; F Horn; S Pellegrini; K Yasukawa; P Heinrich; G R Stark
Journal:  EMBO J       Date:  1995-04-03       Impact factor: 11.598

View more
  9 in total

1.  Receptor-associated constitutive protein tyrosine phosphatase activity controls the kinase function of JAK1.

Authors:  S J Haque; Q Wu; W Kammer; K Friedrich; J M Smith; I M Kerr; G R Stark; B R Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

2.  Functional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signaling.

Authors:  X Li; S Leung; I M Kerr; G R Stark
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

Review 3.  JAKs go nuclear: emerging role of nuclear JAK1 and JAK2 in gene expression and cell growth.

Authors:  Fouad A Zouein; Roy J Duhé; George W Booz
Journal:  Growth Factors       Date:  2011-09-05       Impact factor: 2.511

4.  Janus kinase 3 activity is necessary for phosphorylation of cytosolic phospholipase A2 and prostaglandin E2 synthesis by macrophages infected with Francisella tularensis live vaccine strain.

Authors:  Ashley M Brummett; Aaron R Navratil; Joshua D Bryan; Matthew D Woolard
Journal:  Infect Immun       Date:  2013-12-16       Impact factor: 3.441

5.  Regulation of cytosolic phospholipase A2alpha by hsp90 and a p54 kinase in okadaic acid-stimulated macrophages.

Authors:  Dawn E Tucker; Miguel A Gijón; Diane M Spencer; Zhi-Hua Qiu; Michael H Gelb; Christina C Leslie
Journal:  J Leukoc Biol       Date:  2008-06-11       Impact factor: 4.962

Review 6.  Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action.

Authors:  M A García; J Gil; I Ventoso; S Guerra; E Domingo; C Rivas; M Esteban
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

7.  Differential phosphorylation of PKR associates with deregulation of eIF-2alpha phosphorylation and altered growth characteristics in 3T3-F442A fibroblasts.

Authors:  G Woldehawariat; S Nekhai; R Petryshyn
Journal:  Mol Cell Biochem       Date:  1999-08       Impact factor: 3.842

Review 8.  Immunotherapy of COVID-19 with poly (ADP-ribose) polymerase inhibitors: starting with nicotinamide.

Authors:  Abdulla A-B Badawy
Journal:  Biosci Rep       Date:  2020-10-30       Impact factor: 3.840

9.  Inhibition of p38 mitogen-activated protein kinase impairs influenza virus-induced primary and secondary host gene responses and protects mice from lethal H5N1 infection.

Authors:  Yvonne Börgeling; Mirco Schmolke; Dorothee Viemann; Carolin Nordhoff; Johannes Roth; Stephan Ludwig
Journal:  J Biol Chem       Date:  2013-11-04       Impact factor: 5.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.